This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Innospec Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Innospec Inc. (IOSP) has been struggling lately, but the selling pressure may be coming to an end soon.
US Chemical Industry Rebounds in November As Output Rises
by Anindya Barman
U.S. Chemical production went up across all regions in November barring the Gulf Coast.
Chemicals Start Q4 on Soft Note with Sluggish October Growth
by Anindya Barman
Global chemical production rose a paltry 0.1% in October following flat growth a month ago.
US Chemical Industry Set to Ride High in 2019: 4 Solid Picks
by Anindya Barman
As the U.S. chemical industry is set for solid upside next year, it would be prudent to invest in chemical stocks with compelling growth prospects.
Innospec (IOSP) Launces New Technology for GDI Engines
by Zacks Equity Research
Innospec's (IOSP) new technology will help to reduce emissions from engines and improve fuel economy.
5 Reasons to Add Innospec (IOSP) to Your Portfolio Now
by Anindya Barman
Strong fundamentals and upbeat prospects make Innospec (IOSP) an attractive choice for investment.
Innospec (IOSP) Q3 Earnings Top Estimates, Revenues Up Y/Y
by Anindya Barman
Gains in core business units drove Innospec's (IOSP) results in the third quarter.
Innospec (IOSP) Q2 Earnings Miss Estimates, Sales Up Y/Y
by Zacks Equity Research
While Innospec (IOSP) saw higher sales across its core business units in Q2, its earnings miss expectations.
Zacks Industry Outlook Highlights: Chemours Company, FMC, Methanex and Innospec
by Zacks Equity Research
Zacks Industry Outlook Highlights: Chemours Company, FMC, Methanex and Innospec
Chemical - Diversified Stock Outlook: Good Run to Continue
by Anindya Barman
Notwithstanding some headwinds, the chemical diversified industry's upturn is expected to continue in the near future as the fundamental driving factors remain in place.
Innospec (IOSP) Up 15% in 3 Months: What's Behind the Rally?
by Zacks Equity Research
Solid Q1 results and upbeat prospects have contributed to a rally in Innospec's (IOSP) shares.
Why Innospec (IOSP) Stock Might be a Great Pick
by Zacks Equity Research
Innospec (IOSP) is seeing solid earnings estimate revision activity and is a great company from a Zacks Industry Rank perspective.
5 Reasons to Add Innospec (IOSP) to Your Portfolio Now
by Zacks Equity Research
Strong fundamentals and upbeat prospects make Innospec (IOSP) an attractive choice for investment.
Innospec Initiates Site Construction for DRA Manufacturing
by Zacks Equity Research
Innospec (IOSP) initiates construction of a new site for manufacturing of DRAs in Texas which offers low cost and improved productivity to its customers.
Innospec (IOSP) Q1 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Strong performance across most segments drove Innospec's (IOSP) Q1 results.
What Could Dampen Chemical Industry Momentum?
by Zacks Equity Research
There are a few reasons to be mindful about the chemical industry in the near term.
New Strong Sell Stocks for March 2nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Innospec (IOSP) Q4 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Innospec's (IOSP) adjusted earnings surpassed expectations in Q4 while gains across all segments drove its top line in the quarter.
Here's Why Innospec (IOSP) Should Be in Your Portfolio Now
by Zacks Equity Research
Based on its compelling prospects, we believe Innospec (IOSP) has plenty of upside potential.
Innospec (IOSP) Up 27% in 3 Months: What's Driving It?
by Zacks Equity Research
Solid Q3 results have contributed to a rally in Innospec's (IOSP) shares.
Innospec (IOSP) Q3 Earnings Top Estimates, Sales Rise Y/Y
by Zacks Equity Research
Strong sales gains across all core businesses drove Innospec's (IOSP) Q3 results.
5 Chemical Stocks to Enrich Your Portfolio Before Q3 Earnings
by Zacks Equity Research
Chemical companies are expected to continue the earnings momentum in Q3 as the fundamental driving factors remain firmly in place.
Should Value Investors Consider Innospec (IOSP) Stock Now?
by Zacks Equity Research
Is Innospec Inc. (IOSP) a great pick from the value investor's perspective right now? Read on to know more.
Here's Why Innospec (IOSP) Should Be in Your Portfolio Now
by Zacks Equity Research
Upbeat outlook and compelling growth prospects make Innospec (IOSP) an attractive choice for investment.
Innospec (IOSP) Sets Up Fully-Owned Enterprise in China
by Zacks Equity Research
Innospec (IOSP) announces the completion of its fully-owned enterprise's registration in China. The move is likely to extend the company's footprint in global markets.